Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery
PHASE1CompletedINTERVENTIONAL
Timeline
Start Date
December 31, 1999
Conditions
Lung CancerMetastatic Cancer
Interventions
DRUG
isolated perfusion
DRUG
paclitaxel
PROCEDURE
hyperthermia treatment
Trial Locations (2)
20892
NCI - Center for Cancer Research, Bethesda
20892-1182
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00020007 - Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery | Biotech Hunter | Biotech Hunter